Actively Recruiting
Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients
Led by University Hospital, Antwerp · Updated on 2026-05-08
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying a new mobile application designed to support patients with atrial fibrillation (AF) and heart failure (HF) in managing their health from home. This app aims to actively involve patients in different aspects of their condition and treatment. The study will evaluate how usable the app is, how well patients stick with using it over time, and their satisfaction with the app's follow-up support. Participants will use the Cardio2U application during the follow-up period, which offers educational content about AF and HF, tools to save health appointments, track measurements like heart rate and blood pressure, maintain a medication list with reminders, and complete questionnaires about knowledge, self-care, quality of life, physical activity, and symptoms. The app is personalized to each patient's clinical needs. App usage data and questionnaire responses will be collected at set intervals to assess usability, satisfaction, knowledge, and self-care abilities. Throughout the study, participants will provide information through questionnaires and their app activity will be monitored to understand usage patterns. Doctors and nurses will have access to clinical questionnaire results via a healthcare provider dashboard to help guide patient care. The study will measure changes in usability and satisfaction at 3 and 12 months, and adherence up to 36 months. The total participation time varies, with follow-up assessments occurring up to one year and adherence monitored longer-term.
CONDITIONS
Brief Title
Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with atrial fibrillation, atrial flutter, or heart failure
- Able to give informed consent
You will not qualify if you...
- Unable to speak and read Dutch
- Severe cognitive impairment (e.g., severe dementia)
- No access to a smartphone or tablet
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Up to 36 months
Participants use the mobile application to enter health data, complete questionnaires on usability, satisfaction, knowledge, and self-care, and engage with educational content over the course of the study.
Questionnaires completed at baseline, 1, 3, 6, 12, and up to 36 months; ongoing app use throughout study
Trial Site Locations
Total: 1 location
1
University Hospital Antwerp
Edegem, Antwerp, Belgium, 2650
Actively Recruiting
Research Team
L
Lieselotte Knaepen
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here